Literature DB >> 16406889

Testosterone loss and estradiol administration modify memory in men.

Tomasz M Beer1, Lisa B Bland, Joseph R Bussiere, Michelle B Neiss, Emily M Wersinger, Mark Garzotto, Christopher W Ryan, Jeri S Janowsky.   

Abstract

PURPOSE: Little is known about the effect of androgen deprivation therapy on the brain despite the fact that sex steroid receptors are abundant in cortical brain regions that mediate memory and other cognitive functions. We characterized the impact of androgen deprivation and of subsequent estradiol therapy on the long-term and working memory of patients with prostate cancer.
MATERIALS AND METHODS: Long-term memory (immediate and delayed paragraph recall tests), working memory (SOP and Trails tests) and Profile of Mood States were assessed at baseline and 4 weeks later in 18 patients with androgen independent prostate cancer beginning second line hormonal therapy with transdermal estradiol 0.6 mg/24 hours. The same assessments were performed in 2 age matched control groups of 18 patients with prostate cancer undergoing androgen deprivation continuing on hormonal therapy and 17 community dwelling healthy men.
RESULTS: Immediate and delayed verbal memory were significantly worse in patients with prostate cancer on androgen deprivation than in age matched healthy controls. In addition, men with prostate cancer took more time to complete the Trails A task, indicating slower processing speed, but did not differ significantly from healthy controls in working memory tasks. In individual repeated measures analyses, verbal memory performance improved with estradiol therapy but did not change in the 2 control groups.
CONCLUSIONS: Sex steroid loss and replacement have effects on specific cognitive processes in older men. Furthermore, estrogen has the potential to reverse the neurotoxic effects on memory performance caused by androgen deprivation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16406889     DOI: 10.1016/S0022-5347(05)00049-2

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  35 in total

Review 1.  Mild cognitive impairment and dementia: the importance of modifiable risk factors.

Authors:  Thorleif Etgen; Dirk Sander; Horst Bickel; Hans Förstl
Journal:  Dtsch Arztebl Int       Date:  2011-11-04       Impact factor: 5.594

Review 2.  Hormonal influences on cognition and risk for Alzheimer's disease.

Authors:  Sarah C Janicki; Nicole Schupf
Journal:  Curr Neurol Neurosci Rep       Date:  2010-09       Impact factor: 5.081

Review 3.  Cognitive changes associated with ADT: a review of the literature.

Authors:  Rhoda J Jamadar; Mary J Winters; Pauline M Maki
Journal:  Asian J Androl       Date:  2012-02-20       Impact factor: 3.285

4.  Cardiac and cognitive effects of androgen deprivation therapy: are they real?

Authors:  S M H Alibhai; H Z Mohamedali
Journal:  Curr Oncol       Date:  2010-09       Impact factor: 3.677

Review 5.  Memory and cancer: a review of the literature.

Authors:  Graham J McDougall; JoAnn S Oliver; Forrest Scogin
Journal:  Arch Psychiatr Nurs       Date:  2014-03-22       Impact factor: 2.218

6.  Viral vector-mediated blockade of the endocrine stress-response modulates non-spatial memory.

Authors:  Deveroux Ferguson; Sophia Lin; Robert Sapolsky
Journal:  Neurosci Lett       Date:  2008-03-12       Impact factor: 3.046

Review 7.  Management of complications of androgen deprivation therapy in the older man.

Authors:  Supriya G Mohile; Karen Mustian; Kathryn Bylow; William Hall; William Dale
Journal:  Crit Rev Oncol Hematol       Date:  2008-10-25       Impact factor: 6.312

Review 8.  Cognitive effects of hormone therapy in men with prostate cancer: a review.

Authors:  Christian J Nelson; Jennifer S Lee; Maria C Gamboa; Andrew J Roth
Journal:  Cancer       Date:  2008-09-01       Impact factor: 6.860

9.  Estradiol suppresses tissue androgens and prostate cancer growth in castration resistant prostate cancer.

Authors:  Bruce Montgomery; Peter S Nelson; Robert Vessella; Tom Kalhorn; David Hess; Eva Corey
Journal:  BMC Cancer       Date:  2010-05-28       Impact factor: 4.430

10.  3alpha-androstanediol, but not testosterone, attenuates age-related decrements in cognitive, anxiety, and depressive behavior of male rats.

Authors:  Cheryl A Frye; Kassandra L Edinger; Edwin D Lephart; Alicia A Walf
Journal:  Front Aging Neurosci       Date:  2010-04-08       Impact factor: 5.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.